Stay updated on Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial
Sign up to get notified when there's something new on the Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial page.

Latest updates to the Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange Detected- The page revision label was updated from v3.6.5 to v3.6.6, signaling a small version update to the Study Details page. - This appears to be a backend/template adjustment rather than a change to the study information.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5. This indicates a minor build/template update rather than changes to page content.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, signaling a new revision of the page. This appears to be a minor version bump without an obvious change to visible content.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous Revision: v3.6.2. This indicates an update to the page's underlying platform/version.SummaryDifference0.0%

- Check80 days agoChange DetectedRevision on the page footer updated from v3.6.0 to v3.6.2, indicating a minor page update. The study content and data remain unchanged.SummaryDifference0.0%

- Check95 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating the study is not enrolling at the moment. New navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, the Intervention/Treatment header was reformatted, and a Revision: v3.6.0 tag was introduced.SummaryDifference0.4%

Stay in the know with updates to Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial page.